Thus, simultaneous inhibition of IKKα and IKKβ may provide a way of synergistic targeting in resolution of CS-induced inflammatory response in the lung, and possible devising therapeutic strategies in CS-induced chronic inflammatory diseases including COPD. The gene discussed is CHUK; the disease is chronic obstructive pulmonary disease.